11. Ikegami T, Soejima Y, Shirabe K, Taketomi A, Yoshizumi T, Uchiyama H, Fukuhara T, Ikeda T and Maehara Y. Evolving strategies to prevent bilary strictures after living donor liver transplantation. Transplant Proc. 42(9): 3624-9, 2010
10. Fukuhara T, Taketomi A, Motomura T, Okano S, Ninomiya A, Abe T, Uchiyama H, Soejima Y, Shirabe K, Matsuura Y and Maehara Y. Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C. Gastroenterology. 139(5): 1577-85, 2010
9. Fukuhara T (Corresponding author), Ikegami T, Morita K, Umeda K, Ueda S, Nagata S, Sugimachi K, Gion T, Yoshizumi T, Soejima Y, Taketomi A and Mehara Y. Impact of preoperative serum sodium concentration in living donor liver transplantation. J Gastroenterol Hepatol. 25(5): 978-84, 2010
8. Fukuhara T (Corresponding author), Taketomi A, Okano S, Ikegami T, Soejima Y, Shirabe K and Maehara Y. Mutations in hepatitis C virus genotype 1b and the sensitivity of interferon-ribavirin therapy after liver transplantation. J Hepatol. 52(5): 672-80, 2010
7. Taketomi A, Fukuhara T, Morita K, Kayashima H, Ninomiya M, Yamashita Y, Ikegami T, Uchiyama H, Yoshizumi T, Soejima Y, Shirabe K and Maehara Y. Improved results for a surgical resection for the recurrence of hepatocellular carcinoma after living donor liver transplantation. Ann Sur Oncol. 17(9): 2283-9, 2010
6. Fukuhara T, (Corresponding author), Takeishi K, Toshima T, Morita K, Ueda S, Iguchi T, Nagata S, Sugimachi K, Ikegami T, GIon T, Soejima Y, Taketomi A and Maehara Y. Impact of amino acid substitutions in the core region of HCV on multistep hepatocarcinogenesis. Hepatol Res. 40(2): 171-8, 2010
5. Yamashita Y, Taketomi A, Itoh S, Harimoto N, Morita K, Fukuhara T, Ueda S, Sanefuji K, Sugimachi K, Tajima T and Maehara Y. Phase1/2 study of the lipiodolization using DDP-H (CDDP powder; IA-call) in patients with unresectable hepatocellular carcinoma. Cancer Chemother Pharmacol. 65(2): 301-7, 2010
4. Ito N, Moseley GW, Blondel D, Shimizu K, Rowe CL, Ito Y, Masatani T, Nakagawa K, Jans DA and Sugiyama M. Role of interferon-antagonist activity of rabies virus phosphoprotein in viral pathogenicity. J Virol. 84(13): 6699-6710, 2010
3. Koma T, Yoshimatsu K, Pini N, Safronetz D, Taruishi M, Levis S, Endo R, Shimizu K, Yasuda SP, Ebihara H, Feldmann H, Enria D and Arikawa J. Truncated hantavirus nucleocapsid proteins for serotyping Sin Nombre, Andes, and Laguna Negra hantavirus infections in humans and rodents. J Clin Microbiol. 48(5): 1635-1642, 2010
2. Tegshduuren E, Yoshimatsu K, Taruishi M, Endo R, Shimizu K, Koma T, Yasuda SP, Kariwa H, Arikawa J and Ishihara C. Different cross-reactivity of human and rodent sera to Tula virus and Puumala virus. Comp Immunol Microbiol Infect Dis. 33(6): e67-73, 2010
1. Masatani T, Ito N, Shimizu K, Ito Y, Nakagawa K, Sawaki Y, Koyama H and Sugiyama M. Rabies virus nucleoprotein functions to evade activation of the RIG-I-mediated antiviral response. J Virol. 84(8): 4002-4012, 2010